Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Mereo BioPharma Group

    NASDAQ: MREO · Real-Time Price · USD
    2.77
    0.01 (0.36%)
    At close: Jun 16, 2025, 3:59 PM
    2.83
    1.98%
    After-hours: Jun 16, 2025, 06:24 PM EDT

    Mereo BioPharma Statistics

    Share Statistics

    Mereo BioPharma has 159M shares outstanding. The number of shares has increased by 453.03% in one year.

    Shares Outstanding

    n/a
    		 159M

    Shares Change (YoY)

    n/a
    		 453.03%

    Shares Change (QoQ)

    n/a
    		 401.33%

    Owned by Institutions (%)

    n/a
    		 14.96%

    Shares Floating

    n/a
    		 143.85M

    Failed to Deliver (FTD) Shares

    n/a
    		 453

    FTD / Avg. Volume

    n/a
    		 0.03%

    Short Selling Information

    The latest short interest is 8.42M, so 5.3% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 8.42M

    Short % of Shares Out

    n/a
    		 5.3%

    Short % of Float

    n/a
    		 7.45%

    Short Ratio (days to cover)

    n/a
    		 10.68

    Valuation Ratios

    The PE ratio is -11.97 and the forward PE ratio is -92. Mereo BioPharma's PEG ratio is 0.12.

    PE Ratio

    n/a
    		 -11.97

    Forward PE

    n/a
    		 -92

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 2.3

    PB Ratio

    n/a
    		 8.49

    P/FCF Ratio

    n/a
    		 -15.44

    PEG Ratio

    n/a
    		 0.12
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Mereo BioPharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.4, with a Debt / Equity ratio of 0.11.

    Current Ratio

    n/a
    		 5.4

    Quick Ratio

    n/a
    		 5.4

    Debt / Equity

    n/a
    		 0.11

    Debt / EBITDA

    n/a
    		 -0.14

    Debt / FCF

    n/a
    		 -0.19

    Interest Coverage

    n/a
    		 -34.56

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,201,472.22

    Employee Count

    n/a
    		 36

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 18.2K

    Effective Tax Rate

    n/a
    		 -0.04%

    Stock Price Statistics

    The stock price has increased by -34.82% in the last 52 weeks. The beta is 0.34, so Mereo BioPharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.34

    52-Week Price Change

    n/a
    		 -34.82%

    50-Day Moving Average

    n/a
    		 2.36

    200-Day Moving Average

    n/a
    		 3.23

    Relative Strength Index (RSI)

    n/a
    		 62.26

    Average Volume (20 Days)

    n/a
    		 1,399,192

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -47.36M

    Net Income

    n/a
    		 -43.25M

    EBITDA

    n/a
    		 -47.36M

    EBIT

    n/a
    		 -44.62M

    Earnings Per Share (EPS)

    n/a
    		 -0.29
    Full Income Statement

    Balance Sheet

    The company has 69.8M in cash and 6.43M in debt, giving a net cash position of 63.37M.

    Cash & Cash Equivalents

    n/a
    		 69.8M

    Total Debt

    n/a
    		 6.43M

    Net Cash

    n/a
    		 63.37M

    Retained Earnings

    n/a
    		 -462.88M

    Total Assets

    n/a
    		 68.32M

    Working Capital

    n/a
    		 59.4M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -32.83M and capital expenditures -699K, giving a free cash flow of -33.53M.

    Operating Cash Flow

    n/a
    		 -32.83M

    Capital Expenditures

    n/a
    		 -699K

    Free Cash Flow

    n/a
    		 -33.53M

    FCF Per Share

    n/a
    		 -0.05
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    MREO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for MREO is $7, which is 152.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $7

    Price Target Difference

    n/a
    		 152.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 15.11

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist